Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
J0400528	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2004-04-07	AstraZeneca AB (A wholly owned subsidiary company of AstraZeneca UK Ltd.)	AstraZeneca AB	Certificate Issued	2004-12-08	view
J0400058	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2004-06-11	AstraZeneca AB (A wholly owned subsidiary company of AstraZeneca UK Ltd.)	AstraZeneca AB	Pending Approval	2005-01-24	view
J0400059	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2004-06-11	AstraZeneca AB (A wholly owned subsidiary company of AstraZeneca UK Ltd.)	AstraZeneca AB	Pending Approval	2005-01-24	view
J0400527	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2004-04-07	AstraZeneca AB (A wholly owned subsidiary company of AstraZeneca UK Ltd.)	AstraZeneca AB	Certificate Issued	2004-12-08	view
JYHB1400679	琥珀酸美托洛尔缓释片	metoprolol succinate	Tablet, extended release	Chemical Drugs	Supplementary Application	2014-06-03	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2017-08-09	view
JYHB1000587	盐酸罗哌卡因注射液	ropivacaine hydrochloride	Injection	Chemical Drugs	Supplementary Application	2010-07-15	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2011-07-21	view
JXHL2000269	布地奈德富马酸福莫特罗吸入气雾剂	budesonide;formoterol fumarate	Aerosol	Chemical Drugs(2.2)	Import Drug Application	2020-09-29	AstraZeneca AB	AstraZeneca AB	In Review	2020-09-28	view
JXHL1700117	Olaparib	olaparib	Active ingredient	Chemical Drugs(2.2)	Import Drug Application	2017-07-12	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2017-12-20	view
JXHL1300395	Olaparib	olaparib	Active ingredient	Chemical Drugs	Import Drug Application	2013-10-15	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2014-09-25	view
JYHB0900277	奥美拉唑镁肠溶片	omeprazole magnesium	Tablet	Chemical Drugs	Supplementary Application	2009-04-27	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2009-10-23	view
JYHB1900538	布地奈德格隆溴铵福莫特罗吸入气雾剂	budesonide;formoterol fumarate;glycopyrronium bromide	Aerosol	Chemical Drugs	Supplementary Application	2019-05-15	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2019-12-19	view
JYHB1600536	替格瑞洛片	ticagrelor	Tablet	Chemical Drugs	Supplementary Application	2016-04-20	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2017-07-11	view
JXHL0700011	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs(3.4)	Import Drug Application	2007-01-18	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2009-02-12	view
JYHB1701272	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2017-09-30	AstraZeneca AB	AstraZeneca AB	Filed	2017-10-13	view
JXHL1500194	AZD9291	osimertinib mesylate	Other	Chemical Drugs	Import Drug Application	2015-08-12	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2016-05-20	view
JXHL1300398	Olaparib	olaparib	Active ingredient	Chemical Drugs	Import Drug Application	2013-10-10	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2014-09-25	view
JYHB1400774	注射用奥美拉唑钠	Omeprazole Sodium	Lyophilized	Chemical Drugs	Supplementary Application	2014-06-16	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2015-01-20	view
JYHB1100129	布地奈德鼻喷雾剂	Budesonide	Spray	Chemical Drugs	Supplementary Application	2011-02-22	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2011-06-08	view
JXSL2100018	Benralizumab注射液	benralizumab	Injection	Biological Products(2.2)	Import Drug Application	2021-02-05	AstraZeneca AB	AstraZeneca AB	In Review	2021-02-05	view
JYHB1400148	硫酸特布他林雾化液	terbutaline sulfate	Inhalation	Chemical Drugs	Supplementary Application	2014-02-07	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2017-06-28	view